Metformin promotes apoptosis in hepatocellular carcinoma through the CEBPD-induced autophagy pathway

Metformin, as an AMP-activated protein kinase (AMPK) activator, can activate autophagy. A study showed that metformin decreased the risk of hepatocellular carcinoma (HCC) in diabetic patients. However, the detailed mechanism in the metformin-mediated anticancer effect remains an open question. Trans...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsai, Hsin-Hwa, Lai, Hong-Yue, Chen, Yueh-Chiu, Li, Chien-Feng, Huang, Huei-Sheng, Liu, Hsiao-Sheng, Tsai, Yau-Sheng, Wang, Ju-Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5355142/
https://www.ncbi.nlm.nih.gov/pubmed/28099155
http://dx.doi.org/10.18632/oncotarget.14640

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5355142/
https://www.ncbi.nlm.nih.gov/pubmed/28099155
http://dx.doi.org/10.18632/oncotarget.14640

Ejemplares similares